Arman Oruc has joined Goodwin as a partner in its antitrust and competition practice in Los Angeles. The firm in April added another antitrust partner, Andrew Lacy. Both partners focus on transactions and litigation. Read the Reuters announcement here.
Related Content
- AlertMarch 20, 2025
States Continue to Pursue and Expand Healthcare Market Oversight at an Unprecedented Pace, With Significant Implications for Private Equity
- AlertMarch 12, 2025
FTC’s First Merger Challenge Under New Leadership Signals Return to Traditional Antitrust Theories in Private Equity Deals
- InsightMarch 7, 2025
Antitrust and Competition Technology Year in Review 2024
- InsightFebruary 21, 2025
Antitrust and Competition Life Sciences Year in Review 2024
- InsightJanuary 21, 2025
How the Trump Administration Could Reshape Regulation in the Life Sciences Sector
- AlertJanuary 16, 2025
DOJ Sues Private Equity Firm KKR & Co. for Violations of HSR Act
- AlertJanuary 14, 2025
Massachusetts Passes Comprehensive Revisions to Healthcare Transaction Notification Law with Significant Implications for Private Equity Healthcare Investments
- AlertJanuary 13, 2025
2025 HSR Thresholds Announced: $126.4 million
- Press ReleaseApril 28, 2025
Goodwin Bolsters Brussels Offering with Partner Athena Kontosakou and a Team of Global Antitrust and EU Regulatory Experts
- EventsApril 8, 2025
Boston Forum: Merger Control & Competition in Life Sciences
- Speaking EngagementsApril 3, 2025
Antitrust Considerations for the Pharmaceutical Industry: Pharmacy Benefit Managers (PBMs) and Algorithmic Pricing
- EventsApril 2, 2025
ABA Antitrust Spring Meeting
- Awards and RankingsMarch 21, 2025
Chambers Europe 2025 Recognizes Goodwin Across Belgium and the United Kingdom
- Awards and RankingsMarch 20, 2025
Six Goodwin Lawyers Named to Law360’s 2025 Editorial Advisory Boards
- Press ReleaseMarch 11, 2025
2seventy bio To Be Acquired by Bristol Myers Squibb for $5.00 per Share
- In the PressFebruary 6, 2025
Goodwin Hires Antitrust Partner In DC (Law360)